Tonghua Dongbao (600867.SH) Refined Egg Protein Human Insulin Injection received an overseas drug registration certificate.

Zhtng Cijng APP news, Tonghua Dongbao (600867.SH) announced that the company recently received the drug registration certificate for the insulin injection solution with human islet protein approved and issued by the National Health Regulatory Authority of Nicaragua (ANRS) (registration number: 06000650325). The company's human islet protein mixed insulin injection solution is suitable for type 1 or type 2 diabetes. The main ingredient is human insulin, which is produced through genetic recombination technology. It can promote the uptake and utilization of glucose by tissues such as the liver, muscles, and fat, inhibit glycogen decomposition in the liver, and reduce blood sugar levels. Human islet protein can slow release insulin and prolong its effectiveness.